Blog
RSS FeedPosted by Michael Wonder on 18 Mar 2022
Update to the statutory scheme to control the costs of branded health service medicines
15 March 2022 - The UK Government is seeking views on its proposal to increase the rate of payments made ...
Posted by Michael Wonder on 25 Feb 2022
MAP offers new online pathway for accessing cancer treatments
25 February 2022 - Medicines Australia and Rare Cancers Australia yesterday provided pharmaceutical industry stakeholders a preview of a new ...
Posted by Michael Wonder on 22 Feb 2022
Does the DoH favour some pharmaceutical companies over others?
23 February 2022 - Some interesting insights from version 1 of the agenda for the May 2022 PBAC (intracycle) meeting. ...
Posted by Michael Wonder on 21 Feb 2022
COVID-19 pandemic sends clear message that Australia must value the long-term health of all Australians
21 February 2022 - Medicines Australia is warning that Australia must act now to ensure that our health system is ...
Posted by Michael Wonder on 28 Jan 2022
Australians deserve fast access to the latest medicines, vaccines and treatments
28 January 2022 - Medicines Australia recommends the Australian Government delivers a plan to shorten the time that patients wait ...
Posted by Michael Wonder on 26 Nov 2021
Additional insights from the agenda for the March 2022 PBAC meeting
26 November 2021 - More insights from the MAESTrO Team. ...
Posted by Michael Wonder on 09 Sep 2021
MSD Australia endorses new medicines strategic agreement
8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...
Posted by Michael Wonder on 07 Sep 2021
Landmark new medicines agreements to bring significant benefits for Australian patients
7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...
Posted by Michael Wonder on 07 Sep 2021
New strategic agreements with the medicines industry
7 September 2021 - The Australian Government has entered into new strategic agreements with Medicines Australia and the Generic and ...
Posted by Michael Wonder on 10 May 2021
The Government and Medicines Australia jointly agree to finalise patient centric strategic agreement after the Budget
8 May 2021 - Medicines Australia has been working closely with the Minister and his Department since last year to ...
Posted by Michael Wonder on 18 Mar 2021
Investment in innovative medicines needed to safeguard Australia’s long-term prosperity
17 March 2021 - Medicines Australia has lodged its 2021-22 Pre-Budget Submission with The Treasury which outlines several recommendations to ...
Posted by Michael Wonder on 24 Jan 2021
Canada’s drug makers rattle their sabers over a government plan to control medicine spending
21 January 2021 - A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug spending ...
Posted by Michael Wonder on 13 Jul 2020
Doctors and patients anxious after pharma giant Apotex quits New Zealand
13 July 2020 - A patient advocate group says a pharmaceutical giant's decision to pull out of the New Zealand ...
Posted by Michael Wonder on 10 Jul 2020
Collaborative consultation on medicines policy closes
10 July 2020 - Over the past few months, Medicines New Zealand ran an online consultation on a discussion paper produced ...
Posted by Michael Wonder on 05 Jul 2020
A million Kiwis to be impacted by major pharmaceutical company leaving New Zealand
3 July 2020 - More than a million Kiwis may need to change to different medications before the end of ...